Czechia· CZ-0272650
MRESVIA
A respiratorisches-synzytial-virus impfstoffe product containing respiratory syncytial virus (rsv) mrna vaccine encapsulated in lipid nanoparticles (mresvia), registered in Czechia by MODERNA BIOTECH SPAIN, S.L., Madrid. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- RESPIRATORY SYNCYTIAL VIRUS (RSV) MRNA VACCINE ENCAPSULATED IN LIPID NANOPARTICLES (MRESVIA)
- Manufacturer
- MODERNA BIOTECH SPAIN, S.L., Madrid
- Country
- Czechia (CZ)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Respiratorisches-synzytial-virus impfstoffe in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAbrysvo vaccine powder and solvent for solution for injection 0.5ml vialsPfizer Ltd
- PolandAbrysvoPfizer Europe MA EEIG
- NetherlandsmRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virusModerna Biotech Spain S.L.
- United StatesRespiratory Syncytial Virus NosodeProfessional Complementary Health Formulas
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9f1d26bf-be5c-4070-8f84-3f800974ebb8 GET /v1/drugs/9f1d26bf-be5c-4070-8f84-3f800974ebb8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ DIS ISP",
"source": "sukl",
"strength": null,
"pack_size": "10X0,5ML I",
"substance": "RESPIRATORY SYNCYTIAL VIRUS (RSV) MRNA VACCINE ENCAPSULATED IN LIPID NANOPARTICLES (MRESVIA)",
"cz_kod_sukl": "0272650",
"product_type": "IM/BT",
"substance_codes": "23459",
"registration_state": "R",
"registration_number": "EU/1/24/1849/002"
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.